Cargando…
Development of anti-asthma drugs /
Development of Anti-Asthma Drugs reviews existing asthma treatments and novel approaches currently under investigation, in the context of their mode of action and clinical effectiveness, in the hope that this might lead to a greater understanding of the factors involved in the expression of the dise...
| Clasificación: | Libro Electrónico |
|---|---|
| Otros Autores: | , |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
London ; Boston :
Butterworths,
1984.
|
| Temas: | |
| Acceso en línea: | Texto completo |
MARC
| LEADER | 00000cam a2200000 a 4500 | ||
|---|---|---|---|
| 001 | SCIDIR_ocn561099231 | ||
| 003 | OCoLC | ||
| 005 | 20231117032925.0 | ||
| 006 | m o d | ||
| 007 | cr bn||||||abp | ||
| 007 | cr bn||||||ada | ||
| 008 | 100318s1984 enka ob 001 0 eng d | ||
| 040 | |a OCLCE |b eng |e pn |c OCLCE |d OCLCQ |d OCLCA |d OCLCQ |d OCLCO |d UIU |d OCLCQ |d OCLCF |d IDEBK |d E7B |d N$T |d YDXCP |d OCLCQ |d OCLCA |d STF |d OCLCO |d OCLCA |d OCLCQ |d UKAHL |d UAB |d VLY |d OCLCO |d OCLCQ |d OCL |d OCLCO | ||
| 019 | |a 657968354 |a 899002783 |a 974616945 |a 988556470 |a 1100851477 | ||
| 020 | |z 0408115769 | ||
| 020 | |z 9780408115766 | ||
| 020 | |a 9781483192475 |q (e-book) | ||
| 020 | |a 1483192474 | ||
| 035 | |a (OCoLC)561099231 |z (OCoLC)657968354 |z (OCoLC)899002783 |z (OCoLC)974616945 |z (OCoLC)988556470 |z (OCoLC)1100851477 | ||
| 042 | |a dlr | ||
| 050 | 4 | |a RC591 | |
| 060 | 4 | |a WF 553 |b D489 1984 | |
| 082 | 0 | 4 | |a 616.2/38061 |2 19 |
| 245 | 0 | 0 | |a Development of anti-asthma drugs / |c [edited by] Derek R. Buckle, Harry Smith. |
| 260 | |a London ; |a Boston : |b Butterworths, |c 1984. | ||
| 300 | |a 1 online resource (xii, 403 pages) : |b illustrations | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 504 | |a Includes bibliographical references and index. | ||
| 506 | |3 Use copy |f Restrictions unspecified |2 star |5 MiAaHDL | ||
| 533 | |a Electronic reproduction. |b [Place of publication not identified] : |c HathiTrust Digital Library, |d 2010. |5 MiAaHDL | ||
| 538 | |a Master and use copy. Digital master created according to Benchmark for Faithful Digital Reproductions of Monographs and Serials, Version 1. Digital Library Federation, December 2002. |u http://purl.oclc.org/DLF/benchrepro0212 |5 MiAaHDL | ||
| 583 | 1 | |a digitized |c 2010 |h HathiTrust Digital Library |l committed to preserve |2 pda |5 MiAaHDL | |
| 588 | 0 | |a Print version record. | |
| 505 | 0 | |a Front Cover; Development of Anti-Asthma Drugs; Copyright Page; Preface; Contributors; Table of Contents; Introduction; Part 1: Asthma -- the nature of the disease; Chapter 1. Asthma-the nature of the disease; Definition-what is asthma?; Natural history; Epidemiology; Pathological mechanisms; Part 2: Mediators; Chapter 2. Histamine; Introduction; Histamine release; Actions of histamine; Concluding remarks; Chapter 3. Leukotrienes; Introduction; Structure, formation and metabolism; Biological activities of the leukotrienes; Conclusions; Chapter 4. Platelet-activating factor; Introduction | |
| 505 | 8 | |a Historical overview of platelet-activating factorStructure and metabolism of PAF; PAF production in inflammation; PAF-induced platelet stimulation; Other inflammatory effects of PAF; Physiology; Effects on smooth muscle; Effects of vascular permeability; Pharmacological modulation; Conclusion; Chapter 5. Eosinophils and neutrophils; Introduction; General properties of eosinophils and neutrophils; Allergy and the eosinophil; Allergy and the neutrophil; Inflammatory cells and the progression of asthma; Corticosteroids, eosinophils and neutrophils; Summary; Chapter 6. Acetylcholine; Introduction | |
| 505 | 8 | |a Acetylcholine as a neurotransmitterThe cholinergic nervous system in asthma; Summary; Part 3: Pharmacological approaches; Section 1: Competitive antagonists; Chapter 7. Hi antihistamines Noemi Eiser; Introduction; Effects of H!-receptor antagonists when given to asthmatics by various routes; Conclusions; Chapter 8. SRS-A antagonists; Development of FPL 55712; Biological effects of FPL 55712; Characterization of leukotriene receptors; Other antagonists of SRS-A; Clinical evaluation of SRS-A antagonists; Prospects; Chapter 9. Anti-cholinergic drugs | |
| 520 | |a Development of Anti-Asthma Drugs reviews existing asthma treatments and novel approaches currently under investigation, in the context of their mode of action and clinical effectiveness, in the hope that this might lead to a greater understanding of the factors involved in the expression of the disease and, therefore, in the design of better drugs. It is planned based on the concept of the causes and treatment of asthma, This book is organized in three main parts. Part I deals with the nature of asthma, its pathological mechanisms, natural history and epidemiology. Part II discusses mediators. | ||
| 650 | 0 | |a Antiasthmatic agents. | |
| 650 | 0 | |a Asthma |x Chemotherapy. | |
| 650 | 0 | |a Bronchodilator agents. | |
| 650 | 0 | |a Antihistamines. | |
| 650 | 2 | |a Asthma |x drug therapy |0 (DNLM)D001249Q000188 | |
| 650 | 2 | |a Bronchodilator Agents |0 (DNLM)D001993 | |
| 650 | 2 | |a Histamine Antagonists |0 (DNLM)D006633 | |
| 650 | 2 | |a Anti-Asthmatic Agents |0 (DNLM)D018927 | |
| 650 | 6 | |a Antiasthmatiques. |0 (CaQQLa)201-0027813 | |
| 650 | 6 | |a Asthme |x Chimioth�erapie. |0 (CaQQLa)201-0308318 | |
| 650 | 6 | |a Bronchodilatateurs. |0 (CaQQLa)201-0027814 | |
| 650 | 6 | |a Antihistaminiques. |0 (CaQQLa)201-0020083 | |
| 650 | 7 | |a Bronchodilator agents |2 fast |0 (OCoLC)fst00839417 | |
| 650 | 7 | |a Antihistamines |2 fast |0 (OCoLC)fst00810540 | |
| 650 | 7 | |a Antiasthmatic agents |2 fast |0 (OCoLC)fst00810402 | |
| 650 | 7 | |a Asthma |x Chemotherapy |2 fast |0 (OCoLC)fst00819315 | |
| 653 | |a Man |a Bronchi |a Asthma |a Drug therapy | ||
| 700 | 1 | |a Buckle, Derek R. | |
| 700 | 1 | |a Smith, Harry, |d 1921-2011. | |
| 776 | 0 | 8 | |i Print version: |t Development of anti-asthma drugs. |d London ; Boston : Butterworths, 1984 |w (DLC) 84007057 |w (OCoLC)10696547 |
| 856 | 4 | 0 | |u https://sciencedirect.uam.elogim.com/science/book/9780408115766 |z Texto completo |